Provided By GlobeNewswire
Last update: Aug 13, 2025
NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its 10-Q report today. The following are the highlights of the Company’s financial performance and outlook for 2025.
Read more at globenewswire.comNASDAQ:PRPO (12/5/2025, 8:00:00 PM)
24.02
-0.59 (-2.4%)
Find more stocks in the Stock Screener


